1 completed, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Opioid Induced Constipation (OIC): new trials by email Literature Review of Opioid Induced Constipation (OIC) trials Research Report on Opioid Induced Constipation (OIC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience Naldemedine, an peripherally acting opioid antagonist - Cancer, Opioid Induced Constipation (OIC) | Recruiting | Professor Monique A. H. Steegers | 100 | 2026-01-02 | 2026-01-02 | |
| A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) placebo, NKTR-118 - Opioid Induced Constipation (OIC) | Phase 2 | Completed | AstraZeneca | 207 | 2007-12-01 | 2015-06-12 |
Opioid-Induced Constipation (2) · Constipation (1) · Neoplasms (1)
Chemically-Induced Disorders (2) · Mental Disorders (2) · Narcotic-Related Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Substance-Related Disorders (2) · Constipation (1)
naldemedine (1) · naloxegol (1)
AstraZeneca (1) · Professor Monique A. H. Steegers (1)
Netherlands (1) · United States (1)
Mark Sostek (1)